In a major step against the West Nile virus, the European project LWNVIVAT recently held its kick-off meeting in Barcelona. Over 30 researchers from around the world attended to outline objectives and commit to advancing research and development.

LWNVIVAT is a groundbreaking initiative focused on studying the virus’s characteristics and behavior. This collaboration aims to develop advanced vaccines and antibodies to combat the disease effectively.

During the meeting, participants discussed nine work packages and mapped out the project’s strategic direction. The first session covered novel immunogen design, immunogen production, purification, and characterization, as well as VLP production. After a coffee break, discussions shifted to immunogenicity prediction, candidate molecule studies, monoclonal antibody generation, in vivo research, regulatory plans, GMP manufacturing, and project communication strategies.

The launch of LWNVIVAT marks a united effort against infectious diseases. It underscores the power of international collaboration in advancing public health. The dedication shown at the meeting sets a strong foundation for future success in the fight against the West Nile virus.